{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:54:17Z","timestamp":1759366457426,"version":"build-2065373602"},"reference-count":97,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.revmed.2017.09.007","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T13:01:13Z","timestamp":1507986073000},"page":"728-737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Manifestations ophtalmologiques de la sarco\u00efdose\u00a0: que doit savoir l\u2019interniste\u00a0?"],"prefix":"10.1016","volume":"39","author":[{"given":"P.","family":"S\u00e8ve","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kodjikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Jamilloux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2017.09.007_bib0005","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2017.09.007_bib0010","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.revmed.2017.09.007_bib0015","doi-asserted-by":"crossref","first-page":"e4325","DOI":"10.1097\/MD.0000000000004325","article-title":"The BTNL2\u00a0G16071A gene polymorphism increases granulomatous disease susceptibility: a meta-analysis including FPRP test of 8710\u00a0participants","volume":"95","author":"Tong","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2017.09.007_bib0020","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1034\/j.1399-3003.1999.14d02.x","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for sarcoidosis and other granulomatous disorders","volume":"14","author":"Costabel","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2017.09.007_bib0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/08820530500231938","article-title":"Sarcoidosis","volume":"20","author":"Bonfioli","year":"2005","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0030","doi-asserted-by":"crossref","first-page":"1074e1","DOI":"10.1016\/j.ajo.2010.12.011","article-title":"Orbital and adnexal involvement in sarcoidosis: analysis of clinical features and systemic disease in 30\u00a0cases","volume":"151","author":"Demirci","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00153496","article-title":"Risk factors for ocular sarcoidosis","volume":"72","author":"Rothova","year":"1989","journal-title":"Doc Ophthalmol Adv Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0040","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.autrev.2014.04.001","article-title":"Sarcoidosis and uveitis","volume":"13","author":"Jamilloux","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2017.09.007_bib0045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.revmed.2010.09.003","article-title":"Uv\u00e9ites sarco\u00efdosiques\u00a0: actualit\u00e9s diagnostiques et th\u00e9rapeutiques","volume":"32","author":"Varron","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.09.007_bib0050","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10384-012-0158-z","article-title":"The 2009\u00a0prospective multi-center epidemiologic survey of uveitis in Japan","volume":"56","author":"Ohguro","year":"2012","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0055","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1755-3768.2008.01282.x","article-title":"Clinical features of intraocular inflammation in Hokkaido, Japan","volume":"87","author":"Kitamei","year":"2009","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0060","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2147\/OPTH.S80972","article-title":"Epidemiology of uveitis in the mid-Atlantic United States","volume":"9","author":"Bajwa","year":"2015","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"10.1016\/j.revmed.2017.09.007_bib0065","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1442-9071.2009.02082.x","article-title":"Clinical patterns of uveitis in two ophthalmology centres in Bogota, Colombia","volume":"37","author":"de-la-Torre","year":"2009","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/sj.eye.6702111","article-title":"Pattern of uveitis in a referral centre in Tunisia, North Africa","volume":"21","author":"Khairallah","year":"2007","journal-title":"Eye"},{"key":"10.1016\/j.revmed.2017.09.007_bib0075","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10792-015-0128-9","article-title":"Patterns of uveitis at the Apex Institute for Eye Care in India: results from a prospectively enrolled patient database (2011\u20132013)","volume":"36","author":"Venkatesh","year":"2016","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0080","first-page":"1","article-title":"Etiology and clinical features of ocular inflammatory diseases in a tertiary referral centre in Sydney, Australia","author":"Zagora","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2017.09.007_bib0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/09273948.2011.580071","article-title":"Characteristics of uveitis presenting for the first time in the elderly: analysis of 91\u00a0patients in a tertiary center","volume":"19","author":"Gr\u00e9goire","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2017.09.007_bib0090","doi-asserted-by":"crossref","first-page":"1068e1","DOI":"10.1016\/j.ajo.2013.01.019","article-title":"Association of complement factor H tyrosine 402\u00a0histidine genotype with posterior involvement in sarcoid-related uveitis","volume":"155","author":"Thompson","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0095","first-page":"36","article-title":"Relationship between cytokine single nucleotide polymorphisms and sarcoidosis among Japanese subjects","volume":"30","author":"Kuroda","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2017.09.007_bib0100","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1167\/iovs.12-10491","article-title":"Genetic characterization and susceptibility for sarcoidosis in Japanese patients: risk factors of BTNL2\u00a0gene polymorphisms and HLA class II alleles","volume":"53","author":"Suzuki","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.revmed.2017.09.007_bib0105","first-page":"512","article-title":"Lack of association between IL10\u00a0polymorphisms and sarcoidosis in Japanese patients","volume":"18","author":"Sakuyama","year":"2012","journal-title":"Mol Vis"},{"key":"10.1016\/j.revmed.2017.09.007_bib0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/2011\/185106","article-title":"Association of interleukin 23\u00a0receptor gene with sarcoidosis","volume":"31","author":"Kim","year":"2011","journal-title":"Dis Markers"},{"key":"10.1016\/j.revmed.2017.09.007_bib0115","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1183\/09031936.00025011","article-title":"HLA-DRB1* alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis","volume":"38","author":"Darlington","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2017.09.007_bib0120","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1093\/hmg\/ddq325","article-title":"Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups","volume":"19","author":"Sato","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.revmed.2017.09.007_bib0125","first-page":"2673","article-title":"Lack of association between toll-like receptor 4\u00a0gene polymorphisms and sarcoidosis-related uveitis in Japan","volume":"15","author":"Asukata","year":"2009","journal-title":"Mol Vis"},{"key":"10.1016\/j.revmed.2017.09.007_bib0130","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1399-0039.2008.01043.x","article-title":"Mutation screening of the CARD15\u00a0gene in sarcoidosis","volume":"71","author":"Akahoshi","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.revmed.2017.09.007_bib0135","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1167\/iovs.06-1485","article-title":"Association between heat shock protein 70\/Hom genetic polymorphisms and uveitis in patients with sarcoidosis","volume":"48","author":"Spagnolo","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.revmed.2017.09.007_bib0140","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0002-9394(03)00892-4","article-title":"Uveitis in patients with sarcoidosis is not associated with mutations in NOD2 (CARD15)","volume":"136","author":"Martin","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0145","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1086\/378097","article-title":"HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites","volume":"73","author":"Rossman","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.revmed.2017.09.007_bib0150","doi-asserted-by":"crossref","first-page":"A83","DOI":"10.1016\/j.revmed.2017.03.076","article-title":"Polymorphisme du g\u00e8ne BTNL2\u00a0et uv\u00e9ite sarco\u00efdosique","volume":"38\u00a0Hors-s\u00e9rie","author":"Chaperon","year":"2017","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.09.007_bib0155","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ccm.2015.08.009","article-title":"Ocular sarcoidosis","volume":"36","author":"Pasadhika","year":"2015","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.revmed.2017.09.007_bib0160","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjophthalmol-2016-309767","article-title":"Long-term visual and systemic prognoses of 83\u00a0cases of biopsy-proven sarcoid uveitis","volume":"101","author":"Rochepeau","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0165","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/bjophthalmol-2014-306353","article-title":"Clinical features and diagnostic evaluation of 83\u00a0biopsy-proven sarcoid uveitis cases","volume":"99","author":"Febvay","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0170","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/bjophthalmol-2015-307455","article-title":"Lymphopenia as a predictor of sarcoidosis in patients with uveitis","volume":"100","author":"Jones","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0175","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/09273940902818861","article-title":"International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS)","volume":"17","author":"Herbort","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2017.09.007_bib0180","first-page":"135","article-title":"Diagnostic management of patients with suspected ocular sarcoidosis","volume":"5","author":"Takada","year":"2013","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.revmed.2017.09.007_bib0185","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S1726-4901(08)70047-9","article-title":"Uveitis with biopsy-proven sarcoidosis in Chinese\u00a0\u2014\u00a0a study of 60\u00a0patients in a uveitis clinic over a period of 20\u00a0years","volume":"70","author":"Chung","year":"2007","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.revmed.2017.09.007_bib0190","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archophthalmol.2011.52","article-title":"Clinical features and diagnostic evaluation of biopsy-proven ocular sarcoidosis","volume":"129","author":"Birnbaum","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9394(02)01333-8","article-title":"Chest computerized tomography in the evaluation of uveitis in elderly women","volume":"133","author":"Kaiser","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0200","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bjo.2009.161588","article-title":"Intraocular sarcoidosis: association of clinical characteristics of uveitis with positive chest high-resolution computed tomography findings","volume":"94","author":"Clement","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0205","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.autrev.2017.03.006","article-title":"Relevance of diagnostic investigations in patients with uveitis: retrospective cohort study on 300\u00a0patients","volume":"16","author":"Hadjadj","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2017.09.007_bib0210","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/bjophthalmol-2011-300129","article-title":"Minor salivary gland biopsy in diagnosing ocular sarcoidosis","volume":"95","author":"Blaise","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0215","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00417-012-2178-2","article-title":"Ocular sarcoidosis: when should labial salivary gland biopsy be performed?","volume":"251","author":"Bernard","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0220","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.revmed.2015.07.009","article-title":"\u00c9tude de la pr\u00e9valence des granulomes \u00e0 la biopsie des glandes salivaires accessoires chez 65\u00a0patients atteints de tuberculose","volume":"37","author":"Delcey","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.09.007_bib0225","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1183\/09031936.01.99104501","article-title":"Significance of lymphocytosis in bronchoalveolar lavage in suspected ocular sarcoidosis","volume":"18","author":"Takahashi","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2017.09.007_bib0230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/09273940902788221","article-title":"Fluorodeoxyglucose positron emission tomography for the diagnosis of sarcoidosis in patients with unexplained chronic uveitis","volume":"17","author":"Seve","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2017.09.007_bib0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/bjo.2010.194514","article-title":"Intraocular sarcoidosis: association of clinical characteristics of uveitis with findings from 18F-labelled fluorodeoxyglucose positron emission tomography","volume":"96","author":"Rahmi","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0240","series-title":"Sarcoidosis. Diagnosis and treatment of uveitis","first-page":"710","author":"Stavrou","year":"2002"},{"key":"10.1016\/j.revmed.2017.09.007_bib0245","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/art.20839","article-title":"Association of peripheral multifocal choroiditis with sarcoidosis: a study of thirty-seven patients","volume":"51","author":"Abad","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.09.007_bib0250","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10384-010-0873-2","article-title":"Validation of international criteria for the diagnosis of ocular sarcoidosis proposed by the first international workshop on ocular sarcoidosis","volume":"54","author":"Takase","year":"2010","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/09273948.2015.1032308","article-title":"Flurbiprofen: a nonselective cyclooxygenase (COX) inhibitor for treatment of noninfectious, non-necrotizing anterior scleritis","volume":"24","author":"Agrawal","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2017.09.007_bib0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3109\/09273948.2010.542870","article-title":"Systemic treatment of sarcoidosis","volume":"19","author":"Murray","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2017.09.007_bib0265","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/bjo.84.1.110","article-title":"Ocular involvement in sarcoidosis","volume":"84","author":"Rothova","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0270","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1016\/j.lpm.2012.04.004","article-title":"Ocular sarcoidosis","volume":"41","author":"Bodaghi","year":"2012","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2017.09.007_bib0275","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0161-6420(01)00576-0","article-title":"Methotrexate therapy for chronic noninfectious uveitis: analysis of a case series of 160\u00a0patients","volume":"108","author":"Samson","year":"2001","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2017.09.007_bib0280","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.revmed.2008.08.011","article-title":"Uv\u00e9ites et m\u00e9decine interne\u00a0: strat\u00e9gies diagnostique et th\u00e9rapeutique","volume":"30","author":"Abad","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.09.007_bib0285","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2011.02.048","article-title":"Fluocinolone acetonide intravitreal implant for diabetic macular edema: a 3-year multicenter, randomized, controlled clinical trial","volume":"118","author":"Pearson","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2017.09.007_bib0290","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0295","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/eye.1999.221","article-title":"The ocular and systemic prognosis of patients presenting with sarcoid uveitis","volume":"13","author":"Edelsten","year":"1999","journal-title":"Eye"},{"key":"10.1016\/j.revmed.2017.09.007_bib0300","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0896-1549(02)00021-4","article-title":"Sarcoidosis and uveitis","volume":"15","author":"Jones","year":"2002","journal-title":"Ophthalmol Clin N Am"},{"key":"10.1016\/j.revmed.2017.09.007_bib0305","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0161-6420(99)90011-8","article-title":"Methotrexate treatment for sarcoid-associated panuveitis","volume":"106","author":"Dev","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2017.09.007_bib0310","first-page":"60","article-title":"Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial","volume":"17","author":"Baughman","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2017.09.007_bib0315","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/09273940902862992","article-title":"Mycophenolate mofetil therapy for sarcoidosis-associated uveitis","volume":"17","author":"Bhat","year":"2009","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2017.09.007_bib0320","first-page":"26","article-title":"Management of ocular sarcoidosis","volume":"29","author":"Baughman","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.revmed.2017.09.007_bib0325","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0012-3692(15)50471-6","article-title":"Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial","volume":"128","author":"Baughman","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2017.09.007_bib0330","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.revmed.2017.09.007_bib0335","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semarthrit.2011.12.006","article-title":"Efficacy and safety of TNF antagonists in sarcoidosis: data from the Spanish registry of biologics BIOBADASER and a systematic review","volume":"42","author":"Maneiro","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.09.007_bib0340","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00417-011-1844-0","article-title":"Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis","volume":"250","author":"Erckens","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0345","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.semarthrit.2015.05.010","article-title":"Anti-TNF-\u03b1 therapy in refractory uveitis associated with sarcoidosis: multicenter study of 17\u00a0patients","volume":"45","author":"Riancho-Zarrabeitia","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.09.007_bib0350","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.semarthrit.2017.03.005","article-title":"Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: a multicenter study of 132\u00a0patients","volume":"47","author":"Jamilloux","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.09.007_bib0355","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1509852","article-title":"Adalimumab in patients with active noninfectious uveitis","volume":"375","author":"Jaffe","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2017.09.007_bib0360","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(16)31339-3","article-title":"Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3\u00a0trial","volume":"388","author":"Nguyen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2017.09.007_bib0365","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.revmed.2014.07.008","article-title":"Uv\u00e9ites et bioth\u00e9rapies","volume":"36","author":"Feurer","year":"2015","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.09.007_bib0370","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jbspin.2015.06.002","article-title":"Uveitis in adults: what do rheumatologists need to know?","volume":"82","author":"S\u00e8ve","year":"2015","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.revmed.2017.09.007_bib0375","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.revmed.2010.02.007","article-title":"Agents anti-TNF\u03b1 et sarco\u00efdose","volume":"31","author":"Toussirot","year":"2010","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.09.007_bib0380","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jbspin.2012.05.001","article-title":"Sarcoidosis: an underestimated and potentially severe side effect of anti-TNF-alpha therapy","volume":"80","author":"Vigne","year":"2013","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.revmed.2017.09.007_bib0385","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/09273948.2011.623213","article-title":"Sarcoid-related uveitis occurring during adalimumab therapy","volume":"20","author":"Seve","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2017.09.007_bib0390","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/08820530802007382","article-title":"Neuro-ophthalmic sarcoidosis: the University of Iowa experience","volume":"23","author":"Koczman","year":"2008","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0395","first-page":"99","article-title":"Neurological complications of sarcoidosis","volume":"26","author":"Chen","year":"1989","journal-title":"Clin Exp Neurol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0400","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1212\/NXI.0000000000000270","article-title":"Optic neuropathy associated with systemic sarcoidosis","volume":"3","author":"Kidd","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.revmed.2017.09.007_bib0405","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.revmed.2016.10.392","article-title":"Les atteintes neurologiques au cours de la sarco\u00efdose\u00a0: diagnostic et traitement","volume":"38","author":"Cohen-Aubart","year":"2017","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.09.007_bib0410","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00041327-200309000-00002","article-title":"Sarcoidosis of the anterior visual pathway: 24\u00a0new cases","volume":"23","author":"Frohman","year":"2003","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0415","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/EB.S29401","article-title":"Neuro-ophthalmic sarcoidosis","volume":"4","author":"Baughman","year":"2012","journal-title":"Eye Brain"},{"key":"10.1016\/j.revmed.2017.09.007_bib0420","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00415-017-8444-9","article-title":"Long-term outcomes of refractory neurosarcoidosis treated with infliximab","volume":"264","author":"Cohen-Aubart","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0425","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11910-017-0742-1","article-title":"CNS demyelination with TNF-\u03b1 blockers","volume":"17","author":"Kemanetzoglou","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"10.1016\/j.revmed.2017.09.007_bib0430","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.autrev.2009.10.003","article-title":"Autoimmune diseases induced by biological agents: a double-edged sword?","volume":"9","author":"Ramos-Casals","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2017.09.007_bib0435","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/rheumatology\/kes375","article-title":"Pattern of demyelination occurring during anti-TNF-\u03b1 therapy: a French national survey","volume":"52","author":"Seror","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2017.09.007_bib0440","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/archopht.125.12.1657","article-title":"Orbital and adnexal sarcoidosis","volume":"125","author":"Prabhakaran","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0445","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/IIO.0b013e3181571d65","article-title":"Neuro-ophthalmologic manifestations of sarcoidosis","volume":"47","author":"Braswell","year":"2007","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.revmed.2017.09.007_bib0450","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1750-1172-7-57","article-title":"Uveitis \u2014\u00a0a rare disease often associated with systemic diseases and infections\u00a0\u2014 a systematic review of 2619\u00a0patients","volume":"7","author":"Barisani-Asenbauer","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.revmed.2017.09.007_bib0455","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3899\/jrheum.080102","article-title":"Uveitis subtypes in a german interdisciplinary uveitis center\u00a0\u2014\u00a0analysis of 1916\u00a0patients","volume":"36","author":"Jakob","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0460","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00005792-200107000-00005","article-title":"Chronic severe uveitis: etiology and visual outcome in 927\u00a0patients from a single center","volume":"80","author":"Bodaghi","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2017.09.007_bib0465","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/09273948.2013.855799","article-title":"The Manchester Uveitis Clinic: the first 3000\u00a0patients\u00a0\u2014\u00a0epidemiology and casemix","volume":"23","author":"Jones","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2017.09.007_bib0470","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/aos.12675","article-title":"Epidemiology of uveitis in a Western urban multiethnic population. The challenge of globalization","volume":"93","author":"Lloren\u00e7","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0475","first-page":"A85","article-title":"Aspect cliniques, \u00e9tiologiques et prise en charge des uv\u00e9ites\u00a0: \u00e9tude r\u00e9trospective de 957\u00a0patients","author":"Guillaud","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.09.007_bib0480","doi-asserted-by":"crossref","DOI":"10.1007\/s10792-016-0434-x","article-title":"Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990\u00a0consecutive cases","author":"Luca","year":"2017","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.revmed.2017.09.007_bib0485","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/qjmed\/hcq188","article-title":"Blau syndrome","volume":"104","author":"Martin","year":"2011","journal-title":"QJM"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866317306409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866317306409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:41:12Z","timestamp":1759336872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866317306409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":97,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0248866317306409"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2017.09.007","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manifestations ophtalmologiques de la sarco\u00efdose\u00a0: que doit savoir l\u2019interniste\u00a0?","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2017.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}